References
1. Pyykko I, Nakashima T, Yoshida T, et al. Meniere’s disease: a
reappraisal supported by a variable latency of symptoms and the MRI
visualisation of endolymphatic hydrops. BMJ Open, 2013.3 (2):1-10.
2. Havia M, Kentala E, Pyykkö I, et al. Prevalence of Menière’s
Disease in General Population of Southern Finland. Otolaryngol Head
Neck surg, 2005. 133 (5):762-768.
3. Hallpike CS, Cairns H. Observations on the pathology of
Menie‘re’s syndrome. Proc R Soc Med, 1938. 31 (11): 1317–1336.
4. Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria
for Meniere’s disease. J Vestib Res, 2015. 25 (1):1-7.
5. Belinchon A, Perez-Garrigues H, Tenias JM, et al. Hearing
assessment in Meniere’s disease. Laryngoscope, 2011.121 (3):622-6.
6. Bixenstine PJ, Maniglia MP, Vasanji A, et al. Spiral ganglion
degeneration patterns in endolymphatic hydrops. Laryngoscope, 2008.118 (7):1217-23.
7. Megerian CA. Diameter of the cochlear nerve in endolymphatic
hydrops: implications for the etiology of hearing loss in Meniere’s
disease. Laryngoscope, 2005. 115 (9):1525-35.
8. Zhang W, Xie J, Hui L, et al. The Correlation Between
Endolymphatic Hydrops and blood-labyrinth barrier Permeability of
Meniere Disease. Ann Otol Rhinol Laryngol, 2021.130 (6):578-584.
9. Kim TY, Park DW, Lee YJ, et al. Comparison of Inner Ear
Contrast Enhancement among Patients with Unilateral Inner Ear Symptoms
in MR Images Obtained 10 Minutes and 4 Hours after Gadolinium
Injection. AJNR Am J Neuroradiol, 2015. 36 (12):2367-72.
10. Zhang W, Hui L, Zhang B, et al. The Correlation Between
Endolymphatic Hydrops and Clinical Features of Meniere Disease.Laryngoscope, 2020. 131 (1):1-7.
11. Xie J, Zhang W, Zhu J, et al. Differential Diagnosis of
Endolymphatic Hydrops Between ”Probable” and ”Definite” Meniere’s
Disease via Magnetic Resonance Imaging. Otolaryngol Head Neck Surg,
2021. 165 (5):696-700.
12. Xie J, Zhang W, Zhu J, et al. Comparison of inner ear MRI
enhancement in patients with Meniere’s disease after intravenous
injection of gadobutrol, gadoterate meglumine, or gadodiamide. Eur J
Radiol, 2021. 139 :109682.
13. Huang BY, Zdanski C, Castillo M. Pediatric sensorineural
hearing loss, part 2: syndromic and acquired causes. AJNR Am J
Neuroradiol, 2012. 33 (3):399-406.
14. Hwang M, Zuccoli G. Rapidly Destructive Autoimmune
Labyrinthitis Associated With Ulcerative Colitis. Pediatr Neurol, 2015.53 (4):375-6.
15. Benson JC, Carlson ML, Lane JI. MRI of the Internal Auditory
Canal, Labyrinth, and Middle Ear: How We Do It. Radiology, 2020.297 (2):252-265.
16. Semaan MT, Zheng QY, Han F, et al. Characterization of
Neuronal Cell Death in the Spiral Ganglia of a Mouse Model of
Endolymphatic Hydrops. Otol Neurotol, 2013. 34 (3):559-569.
17. Shi S, Guo P, Li W, et al. Clinical Features and Endolymphatic
Hydrops in Patients With MRI Evidence of Hydrops. Ann Otol Rhinol
Laryngol, 2019. 128 (4):286-292.
18. Yang S, Zhu H, Zhu B, et al. Correlations Between the Degree
of Endolymphatic Hydrops and Symptoms and Audiological Test Results in
Patients With Menièreʼs Disease. Otology & Neurotology, 2018.39 (3):351-356.
19. Huppert D, Strupp M, Brandt T. Long-term course of Meniere’s
disease revisited. Acta Otolaryngol, 2010. 130 (6):644-51.
Figure1 a : The optimal layer was shown at the bilateral
internal auditory canal bottom on 3D-FLAIR image. A
4mm2 ROI was drawn on the bilateral internal auditory
canal bottom and a 50mm2 ROI was drawn on the
cerebellar hemisphere of the corresponding layer.
b : Endolymphatic hydrops in patients with Meniere’s disease on
the right side. Arrow: cochlear hydrops; Triangle: vestibular hydrops.
Figure2 : Endolymphatic hydrops in patients with Meniere’s
disease on the right side. Thick arrow: affected side (signal intensity
ratio: 5.18); Thin arrow: unaffected side (signal intensity ratio: 2.7).
Figure3 : The signal intensity ratio at the auditory canal
bottom on the affected side was significantly higher than that on the
unaffected side (P=0.000).
Figure4: Correlation of signal intensity ratio of internal
auditory canal and low, middle and high tone hearing thresholds in
patients with Meniere’s disease.